# $eikn Eikon Therapeutics sees massive engagement surge, hitting all-time highs in mentions and creator activity. The company is focused on cancer treatments. ### About $eikn Eikon Therapeutics is a cancer-focused biotechnology company. ### Insights - $eikn mentions hit [---] which is 800% higher than it's daily average. - $eikn mentions near a 52-week high at [---]. - $eikn creators hit [--] which is 622% higher than it's daily average. - $eikn creators near a 52-week high at [--]. - $eikn engagements is up 7661.4% from the previous week. - $eikn Mentions hit a 52-Week high of [--] for the day - $eikn Mentions hit an all time of [--] for the day - $eikn Creators hit a 52-Week high of [--] for the day - $eikn Creators hit an all time of [--] for the day ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$eikn/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [-----] +7,661% 1-Year High: [------] on 2026-01-29 1-Year Low: [--] on 2026-01-27 Engagements by network (24h): X: [-----] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$eikn/time-series/posts_active.tsv) Current Value: [---] Daily Average: [--] 1-Year High: [--] on 2026-02-12 1-Year Low: [--] on 2025-10-29 Mentions by network (24h): X: [---] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$eikn/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $eikn in the last [--] hours which is up 103% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [--] on 2026-02-06 1-Year Low: [--] on 2025-10-29 The most influential creators that mention $eikn in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@TTRAmyloid](/creator/twitter/TTRAmyloid) | [--] | [-----] | [--] | [---] | | [@BioStocks](/creator/twitter/BioStocks) | [--] | [------] | [--] | [---] | | [@JacobPlieth](/creator/twitter/JacobPlieth) | [--] | [------] | [--] | [---] | | [@IPOBoutique](/creator/twitter/IPOBoutique) | [--] | [------] | [--] | [---] | | [@lilnickysmith](/creator/twitter/lilnickysmith) | [--] | [---] | [--] | [---] | | [@JPZaragoza1](/creator/twitter/JPZaragoza1) | [--] | [-----] | [--] | [---] | | [@AvgInsider](/creator/twitter/AvgInsider) | [--] | [---] | [--] | [---] | | [@InsideDashboard](/creator/twitter/InsideDashboard) | [--] | [-----] | [--] | [---] | | [@EdgeFromSEC](/creator/twitter/EdgeFromSEC) | [--] | [--] | [--] | [--] | | [@ej23ny](/creator/twitter/ej23ny) | [--] | [-----] | [--] | [--] | [View More](/list/creators/$eikn/100) ### Sentiment: 93%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$eikn/time-series/sentiment.tsv) Current Value: 93% Daily Average: 95% [--] Week: 100% no change 1-Year High: 100% on 2026-01-30 1-Year Low: 83% on 2026-01-29 Most Supportive Themes: - High Engagements: (99%) The cryptocurrency Eikn is experiencing a significant surge in user engagement, with daily engagements reaching 29,191, far exceeding the daily average. - Creator Activity: (1%) There is notable activity from creators discussing Eikn, with [--] unique social accounts posting about it in the last [--] hours. Most Critical Themes: ### Top $eikn Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$NWBO The Column Group used to be the largest shareholder of Immune Design which was developing TLR4 agonist. Now it is one of the main shareholder of Eikon Therapeutics. See something interesting Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma Anatomy of a deal: How Merck closed Immune Design for $300M https://www.fiercebiotech.com/biotech/anatomy-a-deal-how-merck-closed-immune-design-for-300m https://pubmed.ncbi.nlm.nih.gov/34865586/ https://www.thecolumngroup.com/portfolio/ 🚨Insider Trade Alert🚨 10% Owner Column Group IV GP LP has" [X Link](https://x.com/d_stock07734/status/2021379566267142287) [@d_stock07734](/creator/x/d_stock07734) 2026-02-11T00:23Z [---] followers, [----] engagements "🚨 Cluster Buy Alert: $EIKN (Eikon Therapeutics Inc. Common Stock) insiders scooping up shares On Feb [--] [----] [--] participants bought [------] shares worth $9999936. Participants: Lux Venture Partners V LLC (138888 @ $18.00) on Feb [--] [----] Lux Venture Partners V LLC (138888 @ $18.00) on Feb [--] [----] Wolfe Josh (138888 @ $18.00) on Feb [--] [----] Wolfe Josh (138888 @ $18.00) on Feb [--] [----] 💰 Total P&L: -19.4% ($1944432) Price: $14.50 52W: $13.75 (20.5% above)-$17.40 (79.5% below) https://www.averageinsider.com/cluster_buys/1161 https://www.averageinsider.com/cluster_buys/1161" [X Link](https://x.com/AvgInsider/status/2019954287439187970) [@AvgInsider](/creator/x/AvgInsider) 2026-02-07T02:00Z [---] followers, [---] engagements "Not all deals worked. $BOBS traded flat then faded; $AGMB and $EIKN broke issue. $LFTO postponed. Next week: AGI SOLV Energy ARKO Petroleum Clear Street. Windows openbut selective" [X Link](https://x.com/IPOBoutique/status/2019893632434897357) [@IPOBoutique](/creator/x/IPOBoutique) 2026-02-06T21:59Z 15.5K followers, [---] engagements "Biotech VC IPO dogshit $eikn and except public bio funds to gobble it up" [X Link](https://x.com/TTRAmyloid/status/2019812262643687541) [@TTRAmyloid](/creator/x/TTRAmyloid) 2026-02-06T16:35Z [----] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Eikon Therapeutics sees massive engagement surge, hitting all-time highs in mentions and creator activity. The company is focused on cancer treatments.
Eikon Therapeutics is a cancer-focused biotechnology company.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] +7,661%
1-Year High: [------] on 2026-01-29
1-Year Low: [--] on 2026-01-27
Engagements by network (24h): X: [-----]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [--] on 2026-02-12
1-Year Low: [--] on 2025-10-29
Mentions by network (24h): X: [---]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $eikn in the last [--] hours which is up 103% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [--] on 2026-02-06
1-Year Low: [--] on 2025-10-29
The most influential creators that mention $eikn in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TTRAmyloid | [--] | [-----] | [--] | [---] |
| @BioStocks | [--] | [------] | [--] | [---] |
| @JacobPlieth | [--] | [------] | [--] | [---] |
| @IPOBoutique | [--] | [------] | [--] | [---] |
| @lilnickysmith | [--] | [---] | [--] | [---] |
| @JPZaragoza1 | [--] | [-----] | [--] | [---] |
| @AvgInsider | [--] | [---] | [--] | [---] |
| @InsideDashboard | [--] | [-----] | [--] | [---] |
| @EdgeFromSEC | [--] | [--] | [--] | [--] |
| @ej23ny | [--] | [-----] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 93%
Daily Average: 95%
[--] Week: 100% no change
1-Year High: 100% on 2026-01-30
1-Year Low: 83% on 2026-01-29
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NWBO The Column Group used to be the largest shareholder of Immune Design which was developing TLR4 agonist. Now it is one of the main shareholder of Eikon Therapeutics. See something interesting Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma Anatomy of a deal: How Merck closed Immune Design for $300M https://www.fiercebiotech.com/biotech/anatomy-a-deal-how-merck-closed-immune-design-for-300m https://pubmed.ncbi.nlm.nih.gov/34865586/ https://www.thecolumngroup.com/portfolio/ 🚨Insider Trade Alert🚨 10% Owner Column Group IV GP LP has"
X Link @d_stock07734 2026-02-11T00:23Z [---] followers, [----] engagements
"🚨 Cluster Buy Alert: $EIKN (Eikon Therapeutics Inc. Common Stock) insiders scooping up shares On Feb [--] [----] [--] participants bought [------] shares worth $9999936. Participants: Lux Venture Partners V LLC (138888 @ $18.00) on Feb [--] [----] Lux Venture Partners V LLC (138888 @ $18.00) on Feb [--] [----] Wolfe Josh (138888 @ $18.00) on Feb [--] [----] Wolfe Josh (138888 @ $18.00) on Feb [--] [----] 💰 Total P&L: -19.4% ($1944432) Price: $14.50 52W: $13.75 (20.5% above)-$17.40 (79.5% below) https://www.averageinsider.com/cluster_buys/1161 https://www.averageinsider.com/cluster_buys/1161"
X Link @AvgInsider 2026-02-07T02:00Z [---] followers, [---] engagements
"Not all deals worked. $BOBS traded flat then faded; $AGMB and $EIKN broke issue. $LFTO postponed. Next week: AGI SOLV Energy ARKO Petroleum Clear Street. Windows openbut selective"
X Link @IPOBoutique 2026-02-06T21:59Z 15.5K followers, [---] engagements
"Biotech VC IPO dogshit $eikn and except public bio funds to gobble it up"
X Link @TTRAmyloid 2026-02-06T16:35Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$eikn